Clinical Trial Update: Evaluation of the Safety, Efficacy, and Pharmacokinetics of Intravenous Deferiprone in HIV-Positive Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, efficacy, and pharmacokinetics of intravenous deferiprone in asymptomatic HIV-infected subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Asymptomatic HIV Infection | Phase 1 | Status: COMPLETED